Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
362 Leser
Artikel bewerten:
(2)

Liver Transplant Program at Methodist Specialty and Transplant Hospital Recognized as Best in the Nation

Success at Texas Hospital Offers Hope for Millions Affected by Liver-Destroying Hepatitis C

SAN ANTONIO, March 14, 2012 /PRNewswire-USNewswire/ -- Liver transplant surgeons at a San Antonio hospital are poised to save hundreds of lives as deaths from liver-destroying hepatitis C increase, with recent reports indicating baby boomers are highest risk.

(Photo: http://photos.prnewswire.com/prnh/20120314/DC70663)

The Liver Transplant Program at Methodist Specialty and Transplant Hospital (MSTH), a campus of Methodist Hospital, has been recognized as the best liver transplant program in the country, based on data recently released by the Scientific Registry for Transplant Patients.

The MSTH program has the best one-year patient survival rate in the United States among patients with the most seriously advanced liver disease, according to data from the Organ Procurement and Transplant Network (OPTN)/SRTS Annual Data Report. The ranking is based on comparisons of programs performing 10 or more transplants annually.

"Key to becoming the top program in the country is having a hospital and staff devoted to abdominal transplant surgeries with both outpatient and inpatient services," said Preston Foster, M.D., FACS, Surgical Director, Liver Disease and Transplant Program, Texas Transplant Institute, a department of Methodist Hospital. "Our highly experienced and devoted team of physician specialists, nurses and care coordinators consider each patient's individual needs. We provide a continuum of care from diagnosis of liver disease, evaluation for transplant, transplant surgery and recovery, including continued monitoring in our outpatient clinic."

Philip Ostrander, 54, benefited from the outstanding program in San Antonio, surviving more than eight years with his new liver. Ostrander developed liver disease as the result of hepatitis C and cirrhosis of the liver. Just before Thanksgiving in 2003, his condition began to deteriorate. "By January 8, one of the doctors advised my wife to make funeral arrangements," said Ostrander. "Luckily, Dr. Foster said to wait. I was placed on the liver transplant wait list and on January 23 I had my transplant. My transplant gave me a whole new lease on life," Ostrander said.

The MSTH Liver Transplant Program began in 2001 and has performed 290 transplants since that time. Liver transplant procedures can be especially complex because many patients are at life-threatening stages of liver disease and prone to complications. The San Antonio team has implemented several techniques that have resulted in more successful outcomes:

  • Preservation techniques used during transplantation of the donor liver
  • Revascularization techniques of the donor liver
  • Venous bypass machine used to prevent low-blood pressure and low-body temperature during the transplant
  • Techniques to reduce the number of immunosuppressive drugs post transplant
  • Multi-disciplinary care of patients throughout transplant process
  • Aggressive treatment to protect donor liver from hepatitis C

According to the CDC, an estimated 3.2 million Americans have chronic hepatitis C, the leading cause of liver transplants. To read more about the nation's leading liver transplant program and view additional patient profiles, visit bit.ly/y5fLx2.

SOURCE Methodist Healthcare

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.